Shepard; Allan R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shepard; Allan R..The latest application filed is for "rnai inhibition of ctgf for treatment of ocular disorders".

Company Profile

0.3.28

Shepard; Allan R. - Fort Worth TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS App 20140094502 - Shepard; Allan R. ; et al.	2014-04-03
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20120115870 - Fleenor; Debra L. ; et al.	2012-05-10
Prenyltransferase Inhibitors For Ocular Hypertension Control And The Treatment Of Glaucoma App 20120108632 - Shepard; Allan R. ; et al.	2012-05-03
Rnai-mediated Inhibition Of Ocular Hypertension Targets App 20110124708 - Shepard; Allan R. ; et al.	2011-05-26
Pai-1 Expression And Activity Inhibitors For The Treatment Of Ocular Disorders App 20110105574 - Fleenor; Debra L. ; et al.	2011-05-05
Statins For The Treatment Of Ocular Hypertension And Glaucoma App 20110098314 - Hellberg; Mark R. ; et al.	2011-04-28
RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS App 20110028534 - Shepard; Allan R. ; et al.	2011-02-03
RNAi inhibition of CTGF for treatment of ocular disorders Grant 7,838,507 - Shepard , et al. November 23, 2	2010-11-23
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders App 20100247548 - Shepard; Allan R. ; et al.	2010-09-30
Antagonists Of Endothelial Differentiation Gene Subfamily 3 (edg-3, S1p3) Receptors For Prevention And Treatment Of Ocular Disorders App 20100183629 - Fleenor; Debra L. ; et al.	2010-07-22
RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS App 20100166676 - Shepard; Allan R. ; et al.	2010-07-01
Pai-1 Modulators For The Treatment Of Ocular Disorders App 20100158897 - Fleenor; Debra L. ; et al.	2010-06-24
Prenyltransferase Inhibitors For Ocular Hypertension Control And The Treatment Of Glaucoma App 20100120851 - SHEPARD; Allan R. ; et al.	2010-05-13
RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS App 20100035969 - Shepard; Allan R. ; et al.	2010-02-11
RNAi-Mediated Inhibition of Ocular Targets App 20090326044 - Shepard; Allan R. ; et al.	2009-12-31
RNAi inhibition of CTGF for treatment of ocular disorders Grant 7,622,454 - Shepard , et al. November 24, 2	2009-11-24
RNAi-mediated inhibition of ocular targets Grant 7,592,324 - Shepard , et al. September 22, 2	2009-09-22
Pai-1 Expression And Activity Inhibitors For The Treatment Of Ocular Disorders App 20090202524 - Fleenor; Debra L. ; et al.	2009-08-13
Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma App 20090117098 - SHEPARD; Allan R. ; et al.	2009-05-07
Self-complementary Aav-mediated Delivery Of Interfering Rna Molecules To Treat Or Prevent Ocular Disorders App 20090087413 - Shepard; Allan R.	2009-04-02
Inhibitors Of Protein Kinase C-delta For The Treatment Of Glaucoma App 20080153903 - FLEENOR; Debra L. ; et al.	2008-06-26
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders App 20080057072 - SHEPARD; Allan R. ; et al.	2008-03-06
Antagonists Of Endothelial Differentiation Gene Subfamily 3 (edg-3, S1p3) Receptors For Prevention And Treatment Of Ocular Disorders App 20080025973 - FLEENOR; Debra L. ; et al.	2008-01-31
Prenyltransferase Inhibitors For Ocular Hypertension Control And The Treatment Of Glaucoma App 20070232675 - Shepard; Allan R. ; et al.	2007-10-04
C3-Convertase Inhibitors for the Prevention and Treatment of Age-Related Macular Degeneration in Patients With At Risk Variants Of Complement Factor H App 20070149616 - Clark; Abbot F. ; et al.	2007-06-28
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20070142376 - FLEENOR; Debra L. ; et al.	2007-06-21
Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders App 20060275797 - Shepard; Allan R. ; et al.	2006-12-07
RNAi-mediated inhibition of ocular hypertension targets App 20060172963 - Shepard; Allan R. ; et al.	2006-08-03
RNAi-mediated inhibition of ocular targets App 20060172965 - Shepard; Allan R. ; et al.	2006-08-03
RNAi inhibition of CTGF for treatment of ocular disorders App 20060166919 - Shepard; Allan R. ; et al.	2006-07-27
Short form c-Maf transcription factor antagonists for treatment of glaucoma App 20050159432 - Shepard, Allan R. ; et al.	2005-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.